REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/20/2026
Back to search
Official data from USPTO
GK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
07/20/2026
Trademark type
Combined
Nice classes
5, 42, 45
Filing date
09/11/2019
Registration date
07/20/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/20/2021
Last transaction
07/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
JP
Examiner
CHANG, ELIZABETH YI HSUAN
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized Greek letter "Delta" and the stylized Latin letters "GK".
Holders and representatives
Holders
CHUGAI SEIYAKU KABUSHIKI KAISHA (Chugai Pharmaceutical Co., Ltd.)
Representatives
BASSAM N. IBRAHIM BUCHANAN INGERSOLL & ROONEY PC
Technical classification
Nice Classes
Class 5Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use to minimize heterogeneity caused by endogenous enzymes in the course of cell culture for preventing or treating infectious and parasitic diseasescancerblood and blood-forming organs diseases and disorders involving the immune mechanismendocrinenutritional and metabolic diseasesmental and behavioral disordersdiseases of the nervous systemdiseases of the eye and adnexadiseases of the ear and mastoid processdiseases of the circulatory systemdiseases of the respiratory systemdiseases of the digestive systemdiseases of the skin and subcutaneous tissuediseases of the musculoskeletal system and connective tissuediseases of the genitourinary systempregnancychildbirth and the puerperiumcertain conditions originating in the perinatal periodcongenital malformationsdeformations and chromosomal abnormalitiespharmaceutical antibodies or its fragments or its derivatives; cells and genes that produce antibodiesfragments of antibodies or derivatives of antibodies for medical use
Class 42
Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals
Class 45
Granting of licenses to others for the use of industrial property rights and copyright
Publications
History of USPTO decisions and trademark events.
46 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/28/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/10/2022
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
12/01/2021
XXCR
GENERIC MADRID TRANSACTION CREATED
12/01/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/20/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
07/20/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/10/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/04/2021
PUBO
PUBLISHED FOR OPPOSITION
05/04/2021
GPNX
NOTIFICATION PROCESSED BY IB
05/02/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/21/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/21/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/14/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/29/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
03/29/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/29/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
03/29/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/29/2021
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/10/2021
EXPI
EX PARTE APPEAL-INSTITUTED
02/10/2021
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
02/10/2021
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
02/10/2021
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/12/2020
GNFR
FINAL REFUSAL E-MAILED
08/12/2020
CNFR
FINAL REFUSAL WRITTEN
08/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/22/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/22/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/19/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/19/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/19/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/19/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/19/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/19/2020
RFNT
REFUSAL PROCESSED BY IB
02/15/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/24/2020
RFRR
REFUSAL PROCESSED BY MPU
01/24/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/13/2019
CNRT
NON-FINAL ACTION WRITTEN
12/12/2019
DOCK
ASSIGNED TO EXAMINER
12/11/2019
MAFR
APPLICATION FILING RECEIPT MAILED
11/29/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/25/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/21/2019
Continuous trademark protection
Get notified about every new filing that threatens GK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.